We are looking for 2 to 17 years of age to join a UC clinical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderately to severely active ulcerative colitis (including associated symptoms such as fatigue, unexplained weight loss, abdominal pain, frequent fevers and/or eye pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the clinical research if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
